Cargando…

681. Epidemiology and Outcomes of Patients with Carbapenem-Resistant Bloodstream Infection in United States Hospitals, 2010–2015

Mostrar otras versiones (1)

BACKGROUND: Carbapenem resistance (CR) in patients with Gram-negative (GN) bloodstream infections (BSI) presents a mounting therapeutic challenge. To gain a better understanding of CR among patients in US hospitals, we explored their characteristics and outcomes. METHODS: We performed a retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Echols, Roger, Corvino, Frank, Cai, Bin, Lodise, Thomas P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255652/ http://dx.doi.org/10.1093/ofid/ofy210.688

Ejemplares similares

681. Epidemiology and Outcomes of Patients with Carbapenem-Resistant Bloodstream Infection in United States Hospitals, 2010–2015
por: Echols, Roger, et al.
Publicado: (2018)

1191. Prevalence and Microbiology of Carbapenem Resistance Among Six Gram-Negative Pathogens in Bloodstream Infections in US Hospitals, 2010–2015
por: Lodise, Thomas P, et al.
Publicado: (2018)

2163. Risk Factors for Carbapenem-Resistant Gram-Negative Bloodstream Infections (BSI) in U.S. Hospitals (2010–2015)
por: Cai, Bin, et al.
Publicado: (2018)

Current Epidemiology of Serogroup W Meningococcal Disease—United States, 2010–2015
por: Soeters, Heidi, et al.
Publicado: (2017)

164. Analysis of Adult, Hospitalized Patients With Carbapenem-resistant (CR) Gram-Negative Bloodstream Infections (GN-BSIs) due to Lactose Fermenters (LFs) and Non-lactose Fermenters (NLFs): Is There a Difference in Outcomes?
por: Lodise, Thomas, et al.
Publicado: (2019)

The Burden of Bloodstream Infections due to Stenotrophomonas Maltophilia in the United States: A Large, Retrospective Database Study
por: Cai, Bin, et al.
Publicado: (2020)

Epidemiology and Outcomes of Hospitalizations with Invasive Aspergillosis in the United States, 2010–2013
por: Zilberberg, Marya D, et al.
Publicado: (2017)

636. Genome Epidemiology of Carbapenem-Resistant Acinetobacter baumannii (CRAb) in the United States
por: Iovleva, Alina, et al.
Publicado: (2019)

216. Association Between Days to Initiate Appropriate Therapy and Hospital Length of Stay Among Adult Hospitalized Patients With Gram-negative Bloodstream Infections (GN-BSI)
por: Lodise, Thomas, et al.
Publicado: (2019)

1029. Increased Mortality in Hospital-Onset Carbapenem-Resistant Enterobacterales Bloodstream Infections
por: Boutzoukas, Angelique E, et al.
Publicado: (2023)

Epidemiology and Trends of Pertussis among Infants: United States, 2000–2015
por: Bozio, Catherine, et al.
Publicado: (2017)

Influenza-Associated Pediatric Deaths in the United States, 2010–2015
por: Shang, Mei, et al.
Publicado: (2017)

Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa
por: Cai, Bin, et al.
Publicado: (2017)

1004. Frequency of Occurrence and Antimicrobial Susceptibility of Bacteria Isolated From Patients Hospitalized With Bloodstream Infections in United States Medical Centers (2015–2017)
por: Sader, Helio S, et al.
Publicado: (2018)

1715. In Vitro Antibacterial Activity of Cefiderocol against Difficult-to-treat Resistant (DTR) Gram-negative Pathogens in United States from SENTRY Antimicrobial Surveillance Program in 2020/2021
por: Yamano, Yoshinori, et al.
Publicado: (2022)

Epidemiologic evaluation of calcium oxalate urolithiasis in dogs in the United States: 2010‐2015
por: Hunprasit, Vachira, et al.
Publicado: (2019)

2675. Changing Epidemiology of Bloodstream Infection During Chemotherapy for Acute Leukemia: Impact of Prophylactic Fluoroquinolone Restriction and Carbapenem Saving Strategy
por: Yi, Yunmi, et al.
Publicado: (2019)

Epidemiologic Trends in Clostridium difficile Isolate Ribotypes in United States from 2010 to 2014
por: Snydman, David R, et al.
Publicado: (2017)

Use of Carbapenems, Polymyxins, and Tigecycline in United States Children’s Hospitals, 2010–2014
por: Chiotos, Kathleen, et al.
Publicado: (2017)

848. Trends of Carbapenem Resistance in Enterobacterales in the US Between 2015 and 2019
por: Marcella, Stephen, et al.
Publicado: (2020)

1673. Epidemiology of Complicated Urinary Tract Infections (cUTIs) Presenting in Emergency Departments Across the United States (US)
por: Lodise, Thomas, et al.
Publicado: (2020)

1199. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae: A Comparative Study Between Facilities in the United States and the Dominican Republic
por: Mena Lora, Alfredo J, et al.
Publicado: (2018)

2325. Bloodstream Infections in Hospitalized Children in the United States: Incidence, Pathogens, and Regional Differences
por: Spaulding, Alicen B, et al.
Publicado: (2018)

681. Antibiotic Treatment During Hospitalization Is a Major Risk Factor for The Occurrence Of Clostridium Difficile Infection Among Carriers
por: Gilboa, Mayan, et al.
Publicado: (2023)

2302. Bloodstream Infections Due to Carbapenem-Resistant Gram-Negative Bacteria in Pediatric Intensive Care Unit (PICU): Risk Factors and Outcomes
por: Darda, Violetta-Magdalini, et al.
Publicado: (2018)

1162. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified Through the Emerging Infections Program (EIP), United States, 2016–2017
por: Grass, Julian, et al.
Publicado: (2018)

486. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified through the Emerging Infections Program (EIP), United States, 2016–2018
por: Grass, Julian E, et al.
Publicado: (2019)

681. Penicillin Plus Ceftriaxone Against Enterococcus faecalis In Vitro Time-Kill Studies
por: Khan, Ruhmazia, et al.
Publicado: (2021)

In vitro Activity of Cefiderocol against Globally Collected Carbapenem-Resistant Gram-Negative Bacteria Isolated from Urinary Track Source: SIDERO-CR-2014/2016
por: Tsuji, Masakatsu, et al.
Publicado: (2017)

PT681. The protective role of erythropoietin on the cognitive power deficit of the brain and histological changes in the hippocampus of diabetic mice.
por: Ansari, Amer Al, et al.
Publicado: (2016)

Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015
por: Ansari, Uzma, et al.
Publicado: (2017)

1487. Recent Resurgence of Salmonellosis-Related Mortality in the United States, 1990–2015
por: Panchal, Palak, et al.
Publicado: (2019)

1349. Global Surveillance of Cefiderocol Against Gram-Negative Clinical Strains Collected in North America: SIDERO-WT-2015
por: Tsuji, Masakatsu, et al.
Publicado: (2018)

1761. Effect of Carbapenem-Resistant Enterobacteriaceae (CRE) Surveillance Case Definition Change on CRE Epidemiology—Selected US Sites, 2015–2016
por: Duffy, Nadezhda, et al.
Publicado: (2018)

Characteristics of 681 Low Vision Patients in Korea
por: Kim, Jae Hoon, et al.
Publicado: (2010)

Epidemiology of Hospitalized Patients with Babesiosis, United States, 2010–2016
por: Bloch, Evan M., et al.
Publicado: (2022)

246. Carbapenem-resistant Klebsiella (CRK) Bloodstream Infections (BSIs) Are Caused by Bacterial Populations That Are Genotypically and Phenotypically Diverse
por: Nguyen, Minh-Hong, et al.
Publicado: (2019)

Varicella Outbreak Surveillance in the United States, 2015–2016
por: Lopez, Adriana S, et al.
Publicado: (2017)

1256. Clinical Response by Minimum Inhibitory Concentrations in Carbapenem-Resistant Pseudomonas aeruginosa Infections under Cefiderocol Compassionate Use Program
por: Satlin, Michael J, et al.
Publicado: (2021)

Molecular Epidemiology of Carbapenem-Resistant Enterobacter cloacae in a University Hospital in Japan
por: Tetsuka, Nobuyuki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r7kit2k9p0h639an4bffm7b4ou